Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acer MedicalROCO:6857 +0.55%53 3-Year ROIIC % is 648.27 as of Dec. 2025, which is 186% above its 10-year median of 226.78. GuruFocus rates ROCO:6857 with a GF Score™ of 53/100 and a GF Value™ of NT$266.21 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Acer Medical ranks better than 98.38% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Acer Medical's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 648.27%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Acer Medical's 3-Year ROIIC % or its related term are showing as below:
ROCO:6857's 3-Year ROIIC % is ranked better than 98.38% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.48
vs ROCO:6857: 648.27
Acer Medical (ROCO:6857) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Acer Medical 3-Year ROIIC % Related Terms
Acer Medical 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Acer Medical's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6857 vs VEEV, BTSG, HQY: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, Acer Medical's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acer Medical 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Acer Medical's 3-Year ROIIC % falls into.
Acer Medical's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -32.734 (Dec. 2025) - -55.177 (Dec. 2022) )
/
( 11.351 (Dec. 2025) - 7.889 (Dec. 2022) )
=
22.443
/
3.462
=
648.27%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Acer Medical (ROCO:6857) has a 3-Year ROIIC % of 648.27 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Acer Medical and its competitors. This is 186% above median its historical median of 226.78. According to the industry distribution chart, Acer Medical ranks #10 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 1.6%.
Is Acer Medical's 3-Year ROIIC % too high?
Acer Medical's current 3-Year ROIIC % of 648.27 is 186% above median its 10-year median of 226.78. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.48. Acer Medical's value of 648.27 is 18528.4% above this industry median. Based on the distribution chart, Acer Medical ranks #10 out of 619 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Acer Medical has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Acer Medical ranks #10 out of 619 companies for 3-Year ROIIC %. This places Acer Medical in the top 2% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.48. Acer Medical's value of 648.27 is 18528.4% above this benchmark. While the company's 10-year median is 226.78 vs. the industry median of 3.48, Acer Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.48, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acer Medical's current 3-Year ROIIC % of 648.27 is 18528.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Acer Medical and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acer Medical's current 3-Year ROIIC % is 648.27, which is 186% above median its own 10-year median of 226.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$266.21, compared to a current price of NT$92.00 — trading 65.4% below its estimated fair value. The current 3-Year ROIIC % is 648.27, which is 186% above median its 10-year median of 226.78 and 18528.4% above the Healthcare Providers & Services industry median of 3.48. Acer Medical's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current 3-Year ROIIC % is 648.27 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acer Medical (ROCO:6857) Overvalued in 2026?
Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued.
The current stock price of NT$92.00 is trading 65.4% below its estimated GF Value™ of NT$266.21.
GuruFocus considers Acer Medical to be Significantly Undervalued.
Key valuation signals for ROCO:6857:
3-Year ROIIC %: 648.27 (186% above median its 10-year median of 226.78)
GF Value™: NT$266.21 vs. price of NT$92.00 (65.4% below fair value)
Industry Position: 18528.4% above the Healthcare Providers & Services median (#10 of 619)
No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
53GF Score
Get the complete analysis for ROCO:6857
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6857 has been successfully added to your 
